High Tech Pharm Co. Ltd (106190) — Capital Reinvestment Ratio

Latest as of September 2025: 0.08x

High Tech Pharm Co. Ltd (106190) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩6.60 Billion) in capital expenditures (₩516.00 Million). See net asset quality index of High Tech Pharm Co. Ltd to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.08x
Capex / Operating Cash Flow

Operating Cash Flow

₩6.60 Billion
KRW

Capital Expenditures

₩516.00 Million
KRW

Data as of

Sep 2025
Most recent filing

High Tech Pharm Co. Ltd Capital Reinvestment Ratio (2014–2024)

This chart tracks High Tech Pharm Co. Ltd's Capital Reinvestment Ratio across 9 annual periods. Check 106190 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for High Tech Pharm Co. Ltd (2014–2024)

Year-by-year Capital Reinvestment Ratio for High Tech Pharm Co. Ltd from 2014 to 2024. For live market cap and broader valuation context, see how much is High Tech Pharm Co. Ltd worth.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2024 0.15x ₩14.69 Billion ₩2.13 Billion ▼ -91.7%
2023 1.75x ₩2.91 Billion ₩5.09 Billion ▲ +1310.7%
2021 0.12x ₩6.93 Billion ₩859.60 Million ▼ -85.7%
2019 0.87x ₩2.48 Billion ₩2.16 Billion ▼ -47.9%
2018 1.67x ₩5.38 Billion ₩8.96 Billion ▼ -19.4%
2017 2.07x ₩5.45 Billion ₩11.27 Billion ▼ -87.2%
2016 16.13x ₩1.45 Billion ₩23.35 Billion ▲ +950.2%
2015 1.54x ₩12.71 Billion ₩19.52 Billion ▲ +66.5%
2014 0.92x ₩10.17 Billion ₩9.38 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow